The efficacy of eribulin mesylate for patients with cutaneous angiosarcoma previously treated with taxane: a multicentre prospective observational study

Cutaneous Angiosarcoma: The Possibility of New Treatment Options Especially for Patients with Large Primary Tumor

(2018) Yasuhiro Fujisawa et al.   Frontiers in Oncology

An adaptive population enrichment phase III trial of TRC105 and pazopanib versus pazopanib alone in patients with advanced angiosarcoma (TAPPAS trial)

(2018) C R Mehta et al.   ANNALS OF ONCOLOGY

Eribulin versus dacarbazine in previously treated patients with advanced liposarcoma or leiomyosarcoma: a randomised, open-label, multicentre, phase 3 trial

(2016) Patrick Schöffski et al.   LANCET

Combined nivolumab and ipilimumab versus ipilimumab alone in patients with advanced melanoma: 2-year overall survival outcomes in a multicentre, randomised, controlled, phase 2 trial

(2016) F Stephen Hodi et al.   LANCET ONCOLOGY

Infiltration of PD-1-positive cells in combination with tumor site PD-L1 expression is a positive prognostic factor in cutaneous angiosarcoma

(2016) Yuki Honda et al.   OncoImmunology

Paclitaxel Given Once Per Week With or Without Bevacizumab in Patients With Advanced Angiosarcoma: A Randomized Phase II Trial

(2015) Isabelle L. Ray-Coquard et al.   JOURNAL OF CLINICAL ONCOLOGY

Efficacy of Tie2 Receptor Antagonism in Angiosarcoma

(2015) Jason R. Hasenstein et al.   NEOPLASIA

Soft tissue and visceral sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

(2014)   ANNALS OF ONCOLOGY

Chemoradiotherapy with taxane is superior to conventional surgery and radiotherapy in the management of cutaneous angiosarcoma: a multicentre, retrospective study

(2014) Y. Fujisawa et al.   BRITISH JOURNAL OF DERMATOLOGY

First-line anthracycline-based chemotherapy for angiosarcoma and other soft tissue sarcoma subtypes: Pooled analysis of eleven European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group trials

(2014) R.J. Young et al.   EUROPEAN JOURNAL OF CANCER

Treatment and prognostic factors of radiation-associated angiosarcoma (RAAS) after primary breast cancer: A systematic review

(2014) A.L. Depla et al.   EUROPEAN JOURNAL OF CANCER

Angiosarcoma of the scalp in a patient with systemic sclerosis

(2014) Noriko Kubota et al.   JOURNAL OF DERMATOLOGY

Endoglin for Targeted Cancer Treatment

(2014) Lee S. Rosen et al.   Current Oncology Reports

Cutaneous Angiosarcoma: A Single-Institution Experience

(2013) Matthew C. Perez et al.   ANNALS OF SURGICAL ONCOLOGY

Vascular Sarcomas

(2013) Vinod Ravi et al.   Current Oncology Reports

An open-label, multicenter, phase II study of bevacizumab for the treatment of angiosarcoma and epithelioid hemangioendotheliomas

(2012) M. Agulnik et al.   ANNALS OF ONCOLOGY

Comparison between taxane-based chemotherapy with conventional surgery-based therapy for cutaneous angiosarcoma: a single-center experience

(2012) Yasuhiro Fujisawa et al.   JOURNAL OF DERMATOLOGICAL TREATMENT

Sorafenib for Patients with Advanced Angiosarcoma: A Phase II Trial from the French Sarcoma Group (GSF/GETO)

(2012) I. Ray-Coquard et al.   ONCOLOGIST

Natural History of Paclitaxel-Associated Acute Pain Syndrome: Prospective Cohort Study NCCTG N08C1

(2011) Charles L. Loprinzi et al.   JOURNAL OF CLINICAL ONCOLOGY

Eribulin monotherapy versus treatment of physician's choice in patients with metastatic breast cancer (EMBRACE): a phase 3 open-label randomised study

(2011) Javier Cortes et al.   LANCET

Cutaneous angiosarcoma. Analysis of 434 cases from the Surveillance, Epidemiology, and End Results Program, 1973-2007

(2010) Jorge Albores-Saavedra et al.   Annals of Diagnostic Pathology

Partial response to bevacizumab of an extensive cutaneous angiosarcoma of the face

(2010) A. Rosen et al.   BRITISH JOURNAL OF DERMATOLOGY

Outcomes after definitive treatment for cutaneous angiosarcoma of the face and scalp

(2010) B. Ashleigh Guadagnolo et al.   HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK

Cutaneous soft tissue sarcoma incidence patterns in the U.S.

(2008) Panta Rouhani et al.   CANCER

New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)

(2008) E.A. Eisenhauer et al.   EUROPEAN JOURNAL OF CANCER

Phase II Trial of Weekly Paclitaxel for Unresectable Angiosarcoma: The ANGIOTAX Study

(2008) Nicolas Penel et al.   JOURNAL OF CLINICAL ONCOLOGY

Activity and Safety of Pegylated Liposomal Doxorubicin as First-Line Therapy in the Treatment of Non-Visceral Classic Kaposi's Sarcoma: A Multicenter Study

(2008) Giuseppe Di Lorenzo et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Preoperative radiotherapy and bevacizumab for angiosarcoma of the head and neck: Two case studies

(2007) Bridget F. Koontz et al.   HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK